Variant report
Variant | nsv603448 |
---|---|
Chromosome Location | chr6:66345842-66374804 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:66366176..66367861-chr6:66369902..66372494,2 | K562 | blood: | |
2 | chr6:66344295..66347269-chr6:66347639..66350147,2 | MCF-7 | breast: | |
3 | chr6:66366176..66367861-chr6:66369902..66372494,2 | K562 | blood: | |
4 | chr6:66344295..66347269-chr6:66347639..66350147,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LGSN-7 | chr6:66349671-66349785 | NONHSAT113373 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541978110 | chr6:66346006-66346007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs539750541 | chr6:66346020-66346021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1586655 | chr6:66346030-66346031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs570008359 | chr6:66346070-66346071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs537286496 | chr6:66346075-66346076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550710501 | chr6:66346083-66346084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1586656 | chr6:66346089-66346090 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs533189840 | chr6:66346093-66346094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143957991 | chr6:66346102-66346103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567126956 | chr6:66346112-66346113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138554316 | chr6:66346116-66346117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549515310 | chr6:66346130-66346131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1586657 | chr6:66346131-66346132 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs537146273 | chr6:66346153-66346154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557132397 | chr6:66346185-66346186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10944830 | chr6:66346188-66346189 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs553504421 | chr6:66346241-66346242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186248292 | chr6:66346253-66346254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553023988 | chr6:66346272-66346273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573054825 | chr6:66346273-66346274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1586658 | chr6:66346347-66346348 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs545784122 | chr6:66346388-66346389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575391216 | chr6:66346399-66346400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139365915 | chr6:66347412-66347413 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529309340 | chr6:66347418-66347419 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543287647 | chr6:66347433-66347434 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150024091 | chr6:66347449-66347450 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559488642 | chr6:66347462-66347463 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147719196 | chr6:66347469-66347470 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182373660 | chr6:66347476-66347477 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6933242 | chr6:66347501-66347502 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs533060614 | chr6:66347515-66347516 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376630844 | chr6:66347519-66347520 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546419969 | chr6:66347564-66347565 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566449239 | chr6:66347602-66347603 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187871595 | chr6:66347604-66347605 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140861464 | chr6:66347624-66347625 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144707738 | chr6:66347627-66347628 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192601055 | chr6:66347764-66347765 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562569769 | chr6:66347774-66347775 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577461736 | chr6:66347792-66347793 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540318692 | chr6:66347796-66347797 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554007376 | chr6:66347797-66347798 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs6911669 | chr6:66347822-66347823 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs147884281 | chr6:66347853-66347854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs148921809 | chr6:66347864-66347865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114376809 | chr6:66347885-66347886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545764981 | chr6:66347889-66347890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12207870 | chr6:66347911-66347912 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs527924726 | chr6:66347914-66347915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Retinitis pigmentosa | 21519034 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66346000-66346400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr6:66347400-66347600 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr6:66347600-66347800 | Flanking Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr6:66347600-66348000 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr6:66347600-66348400 | Enhancers | Placenta | Placenta |
6 | chr6:66347800-66348800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr6:66348400-66348800 | Enhancers | Adipose Nuclei | Adipose |
8 | chr6:66348400-66348800 | Enhancers | Pancreas | Pancrea |
9 | chr6:66359400-66360200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr6:66359600-66360600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr6:66359600-66360800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr6:66359600-66361600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr6:66359800-66360600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr6:66360000-66360400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr6:66360400-66360800 | Active TSS | Pancreatic Islets | Pancreatic Islet |
16 | chr6:66374000-66375200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |